Before the opening bell on Monday morning, Cal-Maine Foods Inc (CALM)�reported its third quarter earnings, posting higher revenues and earnings than last year’s same period.
CALM’s Earnings in Brief
CALM reported third quarter sales of $395.5 million, which were up from last year’s Q3 revenues of $360.4 million. Net income for the quarter came in at $42.9 million, or $1.77 per diluted share, up from last year’s earnings of $30.6 million, or $1.27 per share. Cal-Maine blew analysts’ EPS estimates of $1.41 out of the water.CEO Commentary
Top 10 Gas Utility Companies To Buy Right Now: Cytori Therapeutics Inc(CYTX)
Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical products and devices to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. Its principal products include the Celution family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzyme reagents, and related instrumentation. Its core product, the Celution System, provides physicians with clinical grade stem and regenerative cells for use in the cosmetic and reconstructive surgery market. The company also provides PureGraft, a consumable product that provides grafts for use in aesthetic body contouring procedures. In addition, it sells the StemSource family of products worldwide, including in the United States, for research, as well as for the cryopreservation and storage of ADRCs. It offers the StemSource System as a standalone product, or as a part of a comprehensive suite of systems, equipment, and protocols collectively referred to as a StemSource Cell Bank. Further, the company develops Celution System, which has completed two clinical trials for applications in cardiovascular disease, wound healing, gastrointestinal disorders, stress urinary incontinence, liver and renal disease, spinal disc degeneration, and pelvic health conditions. It has strategic development and manufacturing joint venture agreement, and other related agreements with Olympus Corporation. The company was formerly known as MacroPore Biosurgery, Inc. Cytori Therapeutics, Inc. was founded in 1996 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
Cytori Therapeutics Inc.(CYTX) on Tuesday said it is putting a clinical hold on enrollment in two chronic-heart-failure clinical trials, citing safety concerns. Shares sank 32.9% to $1.41 premarket.
5 Best Diversified Bank Stocks To Own For 2014: Prospect Capital Corporation(PSEC)
Prospect Capital Corporation is a mezzanine finance and private equity firm that specializes in late venture, middle market, mature, mezzanine, buyouts, recapitalizations, growth capital, development, and bridge transactions. It makes secured debt and equity investments. The firm typically invests across all industry sectors, with a particular expertise in the energy and industrial sectors. It invests in oil and gas production, coal production, materials, industrials, consumer discretionary, information technology, utilities, pipeline, storage, power generation and distribution, renewable and clean energy, oilfield services, healthcare, food and beverage, education, business services, and other select sectors. The firm prefers to invest in the United States and Canada. It seeks to invest between $5 million to $50 million in companies with EBITDA between $$ million and $75 million, sales value up to $500 million, and enterprise value of up to $250 million. The firm also co- invests for larger deals. It seeks control acquisitions by providing multiple levels of the capital structure. Prospect Capital Corporation was founded in 1988 and is based in New York, New York.
Advisors' Opinion:- [By James E. Brumley]
What do Prospect Capital Corporation (NASDAQ:PSEC), Astec Industries, Inc. (NASDAQ:ASTE), and First Financial Corp. (NASDAQ:THFF) have in common? Not much, on the surface. In fact, were it not for something very specific to one particular person (me), they'd have nothing in common at all. This week though, THFF, ASTE, and PSEC all have at least one thing in common, and that's the fact that they're all going into my mental/hypothetical portfolio.
- [By Lauren Pollock]
Prospect Capital Corp.(PSEC) said it agreed to buy Nicholas Financial Inc.(NICK) in a stock deal valued at about $199 million that the investment firm expects will expand its presence in the car-loan industry. Prospect Capital is offering $16 a share for Nicholas, a 4.5% premium over Tuesday’s closing price. Nicholas Financial shares edged up 2.8% to $15.70 premarket.
5 Best Diversified Bank Stocks To Own For 2014: iShares Russell 2000 Value ETF (IWN)
iShares Russell 2000 Value Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Russell 2000 Value Index (the Index). The Index measures the performance of the small-capitalization value sector of the United States equity market. It is a subset of the Russell 2000 Index. The Index is a capitalization-weighted index and consists of those companies or portion of a company, with lower price-to-book ratios and lower forecasted growth within the Russell 2000 Index. The Index represents approximately 50% of the total market capitalization of the Russell 2000 Index.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. iShares Russell 2000 Value Index Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By John Udovich]
Yesterday, Luna Innovations Incorporated (NASDAQ: LUNA), a rather unusual and innovative small cap stock,�soared some 23.26%���meaning its worth taking a closer look at the stock along with its performance verses the performance of small cap benchmarks like the iShares Russell 2000 Index ETF (NYSEARCA: IWM), the�iShares Russell 2000 Value Index ETF (NYSEARCA: IWN) or the iShares Russell 2000 Growth Index ETF (NYSEARCA: IWO).
- [By John Udovich]
Small cap custom carry and protective solutions stock Forward Industries, Inc (NASDAQ: FORD) jumped 22.51% earlier today as an apparent turnaround continues, meaning its worth taking a closer look at a stock that�� in a decidedly niche area plus look at the performance of potential investment benchmarks like the iShares Russell 2000 Index ETF (NYSEARCA: IWM), iShares Russell 2000 Growth Index ETF (NYSEARCA: IWO) and iShares Russell 2000 Value Index ETF (NYSEARCA: IWN).
5 Best Diversified Bank Stocks To Own For 2014: Euromedis Groupe SA (EMG)
Euromedis Groupe SA is a France-based company that specializes in the design, manufacture, distribution, rental and export of medical and surgical equipment and products, and services for medical home care for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The Company's product portfolio include products, such as syringes and needles; surgical equipment, such as catheters, instrumentation and compresses; gloves; hygiene products, comprising disposable clothing, masks and paper towel products, and pharmaceutical equipment, offering cotton wool and thermometers. Euromedis Groupe SA exports its products to Europe and Africa. Advisors' Opinion:- [By Sofia Horta e Costa]
Man Group Plc (EMG) jumped 6.8 percent to 104.3 pence. The world�� largest publicly traded hedge-fund manager said it no longer needs to hold a $300 million capital buffer after it confirmed with the U.K.�� Financial Conduct Authority a change in the company�� regulatory status.
- [By Sofia Horta e Costa]
Commodity producers increased as base metals rallied, with BHP Billiton Ltd. (BHP), the largest mining company, climbing 3.7 percent. Man Group (EMG) Plc soared 13 percent on a plan to redeem debt. Royal Bank of Scotland Group Plc dropped by the most in two months after Britain�� biggest state-owned lender reported operating profit that fell short of analysts��estimates.
- [By Inyoung Hwang]
Man Group Plc (EMG) advanced 3.6 percent to 85.85 pence. The world�� largest publicly traded hedge-fund manager posted its first quarterly net inflows in two years as clients added money to funds at its GLG Partners unit. Sales of Man Group�� funds totaled $4.1 billion in the third quarter, exceeding $3.4 billion of redemptions.
No comments:
Post a Comment